New Zealand - Re-Export of Heparin for Therapeutic Use
Since 2014, New Zealand Re-Export of Heparin for Therapeutic Use increased 141.8% year on year. At $90,204.13 in 2019, the country was number 6 comparing other countries in Re-Export of Heparin for Therapeutic Use. New Zealand is overtaken by Jordan, which was ranked number 5 with $114,511.44 and is followed by United Arab Emirates with $46,048.8. United States lead the ranking with $4,598,060.57 in 2019, that is a fall of 5.2% compared to 2018. Canada, Barbados and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. New Zealand witnessed the best average annual growth at +141.8% per year, while United States recorded the worst performance at -29.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 90,204.13 |
| 2018 | 93,634.80 |
| 2017 | 137,060.77 |
| 2016 | 14,510.10 |
| 2015 |
Download all data from 1989 to 2019
How does New Zealand rank in Re-Export of Heparin for Therapeutic Use?
| # | 10 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
4,598,060.57 | 2019 | -5.2 % | -29.7 % | View data | |
| 2 |
#2
Canada
|
728,579.06 | 2019 | +2.9 % | +13.3 % | View data | |
| 5 |
#5
Jordan
|
114,511.44 | 2019 | -6.3 % | -22.7 % | View data | |
| 6 |
#6
New Zealand
|
90,204.13 | 2019 | -3.7 % | +141.8 % | View data | |
| 7 |
#7
United Arab Emirates
|
46,048.80 | 2019 | -14.7 % | +23.1 % | View data | |